SCHEMBL7656443

SCHEMBL7656443

CCNC1CCc2[nH]c3ccc(NC(=O)c4ccccc4OC)cc3c2C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.47
KCNK3 O14649 3/20 0.46
KCNK9 Q9NPC2 3/20 0.46
CASP3 P42574 1/20 0.45
KMT2A Q03164 3/20 0.44
POLB P06746 2/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HTR1A P08908 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657003 0.89 HTR1F (0.48) HTR1FKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7658867 0.87 HTR1F (0.51) HTR1FMAPTHTTSMN1; SMN2HTR1A
SCHEMBL7663031 0.87 JAK2 (0.49) HTR1FKMT2ACHRM5CHRM1CHRM3
SCHEMBL7654364 0.86 MEN1 (0.46) HTR1FKMT2AMEN1HTR1AHTR1D
SCHEMBL8116691 0.86 HTR1F (0.45) HTR1FKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7656407 0.85 HTR1F (0.56) HTR1FKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7666175 0.85 HTR1A (0.50) HTR1FKMT2AMEN1HTR1AHTR1D
SCHEMBL7655587 0.84 JAK2 (0.51) HTR1FKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7660703 0.84 HTR1F (0.49) HTR1FKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL7656434 0.84 HTR1F (0.68) HTR1FKCNK3KCNK9CASP3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
WO-1998011895-A1 A METHOD FOR THE PREVENTION OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-03-26 WO disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed